Public Health Trace

Get Alerts

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to November 2026.

37,450

Total recall recordsAll FDA and USDA recalls in Public Health Trace

9,872

Class I recallsReasonable probability of serious health consequences

24,509

Class II recallsTemporary or medically reversible health consequences

2,932

Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls

Most common hazardLack of Assurance of Sterility 2,096 recalls

Newest recallhttp://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/fresh-ready-foods-llc-recalls-fresh-you-brand-sausage-egg-cheese-biscuit-sandwich-due-possiblePublished November 8, 2026

Most affected stateHawaii 200 recalls mention this state

Advertisement

State: MD ×
Clear all

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters

Timeline Classification Table

Metric

Time range

Group by

View

Recalls announced by month (Year to date)

Download CSV

Source: FDA and USDA public dataLast updated November 9, 2026 ET

Summary (Year to date)

1,956 recalls have been announced year to date.
Oct 2026 was 4% higher than the previous complete period (Sep 2026: 209).
The highest complete period was Jun 2026 (300).
Nov 2026 is incomplete and not included in the figures above.

Complete data
Incomplete

Recalls by class

Recalls by class
Class	Recalls
Class II	24,509
Class I	9,872
Class III	2,932
Not Yet Classified	2

Recalls by class
Class	Recalls
Class II	24,509
Class I	9,872
Class III	2,932
Not Yet Classified	2

FDA Recall United States TerminatedTerminated: August 31, 2017Historical recordClass I

Lords Organics Llc

Product: Organic Veda brand Ginger Powder, 24 jars, Net Wt. 16 oz. (4…
Reason: Lord Organics is recalling ginger powder because it has the potential to be contaminated with Salmonella.
Published: May 31, 2017
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: August 24, 2021Historical recordClass III

Fluocinonide Cream UPS, 0.05% (Emulsified Base), packaged in 60 g tube, Rx only, Mfd. by: Taro Pharmaceuticals Inc., Brampton, Ontario, Canada, Dist. by Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532, NDC 51672-1254-3

by Taro Pharmaceuticals U.S.A., Inc.

Reason: Cross contamination with other products: Certain lots of Fluocinonide Cream were found to be contaminated with a small quantity of hydrocortisone-17-valerate.
Published: May 24, 2017
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: August 29, 2017Historical recordClass II

VITAMIN D3 IN OLIVE OIL SDV 100,000U/ML INJ, Injection, 150,000u/mL, Rx only, packaged in 2mL Glass/Single Dose vial, Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason: Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Published: May 24, 2017
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: August 29, 2017Historical recordClass II

VITAMIN D3 IN OLIVE OIL SDV 100,000U/ML INJ, Injection, 100,000u/mL, Rx only, packaged in 1 mL Glass/Single Dose vial, Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason: Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Published: May 24, 2017
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: August 29, 2017Historical recordClass II

VITAMIN B COMPLEX 1ML SDV NA INJ, Injection, 100mg/2mg/2mg/2mg/100mg/mL, Rx only, 1mL Glass; Single Dose, Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason: Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Published: May 24, 2017
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: August 29, 2017Historical recordClass II

TESTOST AQ MDV 50MG/ML INJ, Injection, 50mg/mL, Rx only, packaged in 5mL and 10mL Glass/Multiple Dose vial, Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason: Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Published: May 24, 2017
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: August 29, 2017Historical recordClass II

TESTOST CYP SESAME OIL 5ML MDV 100MG/ML INJ, Injection, 100mg/mL, Rx only, 5 mL Glass/Multiple Dose vial, Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason: Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Published: May 24, 2017
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: August 29, 2017Historical recordClass II

SOD PHENYLBUTYRATE SDV 30ML (CALIF or NEZ-CALIF) 200MG/ML INJ, Injection, 200mg/mL, Rx only, 30 mL Glass/Single Dose vial, Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason: Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Published: May 24, 2017
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: August 29, 2017Historical recordClass II

SODIUM CHLORIDE INH PF GV 0.9% SOLN, Inhalation Solution, 0.90%, Rx only, 5mL Glass/Single Dose vial, Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason: Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Published: May 24, 2017
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: August 29, 2017Historical recordClass II

SODIUM CARBOXYM-CELL PF 0.5% OPHTH, opthalmic, 0.50%, Rx only, 10mL Glass/Multiple Dose vial, Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason: Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Published: May 24, 2017
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: August 29, 2017Historical recordClass II

SODIUM BICARB 50ML MDV 8.4% (2 MOSMOL/ML) INJ, Injection, 8.40%, Rx only, 5mL Glass/Multiple Dose via, Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason: Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Published: May 24, 2017
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: August 29, 2017Historical recordClass II

PYRIDOXAL-5-PHOS 5ML MDV 50MG/ML INJ, 50mg/mL, Rx only, 5mL Glass/Multiple Dose vial, Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason: Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Published: May 24, 2017
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: August 29, 2017Historical recordClass II

PYRIDOXAL-5-PHOS 10ML MDV 100MG/ML INJ, Injection, 100mg/mL, Rx only, 10mL Glass/Multiple Dose vial, Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason: Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Published: May 24, 2017
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: August 29, 2017Historical recordClass II

PROGESTERONE SESAME OIL 10ML MDV 100MG/ML INJ, Injection, 100mg/mL, Rx only, 10mL Glass; Multiple Dose vial, Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason: Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Published: May 24, 2017
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: August 29, 2017Historical recordClass II

PROCAINE HCL SDV 2% INJ, Injection, 2%, Rx only, packaged in 10mL and 50 mL Glass/Single Dose vials, Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason: Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Published: May 24, 2017
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: August 29, 2017Historical recordClass II

PROCAINE HCL SDV 1% INJ, Injection, 1%, Rx only, packaged in 5mL and 50 mL Glass/Single Dose vials, Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason: Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Published: May 24, 2017
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: August 29, 2017Historical recordClass II

PROCAINE HCL 5ML SDV SULFITE FREE 1% INJ, Injection, 1%, RXxonly, 5mL Glass/Single Dose vials, Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason: Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Published: May 24, 2017
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: August 29, 2017Historical recordClass II

PROCAINE HCL 50ML MDV (CALIF) 1% INJ, Injection, 1%, Rx only, 50mL Glass/Multiple Dose vial, Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason: Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Published: May 24, 2017
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: August 29, 2017Historical recordClass II

METHYL-B12 10ML MDV 5MG/ML INJ, Injection, 5mg/mL, Rx only, 10 mL Glass/Multiple Dose vial, Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason: Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Published: May 24, 2017
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: August 29, 2017Historical recordClass II

METHYL-B12 5ML MDV (CALIF) 1MG/ML INJ, Injection, 1mg/mL, Rx only, 5 mL Glass/Multiple Dose vial, Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason: Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Published: May 24, 2017
Distribution: Nationwide

View recall →

Data last updated: November 9, 2026 ET

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.